USER INTERFACE FOR TESTING DEVICE

• US 20090305317A1
• Filed: 05/19/2009
• Published: 12/10/2009
• Est. Priority Date: 06/05/2008
• Status: Abandoned Application

• Current Assignee: Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
• Original Assignee: Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
• Inventors: Brauer, Jacob S., Sommer, Fred, Rountree, Dawn, Chen, Jun, Lin, Jing, Wu, Huan-Ping, Brown, Darren, Chang, Kevin, Kates, Richard, Yao, Raymond, Lieber, Harris, Tsai, Fu Hsiung, Schwartz, Amy, Levin, Jennifer M.
• Application Number:
  US12/468,671
• Publication Number:
  US 20090305317A1
• Time in Patent Office: Days
• US Class Current: 435/14
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions
• CPC Class Codes: C12Q 1/004 mediator-assisted
• CPC Class Codes: G01N 27/3274 Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration coding of calibration information G01N33/48771
• CPC Class Codes: G01N 33/96 involving blood or serum control standard

Abstract

A testing system for testing an analyte in a fluid sample includes a user interface including a display for displaying information relating to measurements of health data and an input device for receiving information from a user relating to the health data. The testing system further includes an automarking feature adapted to identify a testing result of a control solution, the testing of the control solution being distinguishable from the testing of the fluid sample. The testing result of the control solution is not included in the information relating to the measurements of health data that is displayed to a user via the user interface.

Claims

1. A testing system for testing an analyte in a fluid sample, comprising:

a user interface including a display for displaying information relating to measurements of health data and an input device for receiving information from a user relating to the health data; and

an automarking feature adapted to identify a testing result of a control solution, the testing of the control solution being distinguishable from the testing of the fluid sample, and wherein the testing result of the control solution is not included in the information relating to the measurements of health data that is displayed to a user via the user interface.

2. The testing system of claim 1, wherein the automarking feature identifies the testing result of the control solution due to the presence of a control marker in the control solution.

3. The testing system of claim 2, wherein the control marker is an oxidizable species that is oxidizable only at voltages higher than those used for the analyte measurements.

4. The testing system of claim 1, wherein the user interface displays the result of the control solution testing.

5. The testing system of claim 4, wherein the user interface includes an icon for indicating a control solution testing result.

10. The method of claim 1, further comprising displaying the result of the control solution testing via the user interface.

11. The method of claim 10, wherein the user interface includes an icon for indicating a control solution testing result.

6. A method of testing an analyte in a fluid sample, the method comprising the acts of:

identifying a testing result of a control solution using an automarking feature;

distinguishing the testing result of a control solution from a testing result of the fluid sample; and

displaying information relating to measurements of health data on a user interface, the testing result of the control solution not being included in the information relating to the measurements of health data.

7. The method of claim 6, further comprising receiving information from a user relating to health data via a user interface.

8. The method of claim 6, wherein the act of identifying the testing result of the control solution includes detecting the presence of a control marker in the control solution.

9. The method of claim 8, wherein the control marker is an oxidizable species that is oxidizable only at voltages higher than those used for the analyte measurements.